Literature DB >> 24255607

Quality of life.

Samuel Charache1.   

Abstract

Entities:  

Year:  2013        PMID： 24255607      PMCID： PMC3832304          DOI： 10.5581/1516-8484.20130102

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN： 1516-8484


× No keyword cloud information.
  8 in total

1.  Building a medical neighborhood for the medical home.

Authors:  Elliott S Fisher
Journal:  N Engl J Med       Date:  2008-09-18       Impact factor: 91.245

2.  Current management of sickle cell anemia.

Authors:  Patrick T McGann; Alecia C Nero; Russell E Ware
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

Review 3.  Gene therapy for hemoglobinopathies: progress and challenges.

Authors:  Alisa Dong; Stefano Rivella; Laura Breda
Journal:  Transl Res       Date:  2013-01-19       Impact factor: 7.012

4.  Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach.

Authors:  Javid Gaziev; Marco Marziali; Antonella Isgrò; Pietro Sodani; Katia Paciaroni; Cristiano Gallucci; Marco Andreani; Manuela Testi; Gioia De Angelis; Cecilia Alfieri; Luisa Cardarelli; Michela Ribersani; Daniele Armiento; Guido Lucarelli
Journal:  Blood       Date:  2013-08-20       Impact factor: 22.113

5.  The patient-centered medical home in the Veterans Health Administration.

Authors:  Ann-Marie Rosland; Karin Nelson; Haili Sun; Emily D Dolan; Charles Maynard; Christopher Bryson; Richard Stark; Joanne M Shear; Eve Kerr; Stephan D Fihn; Gordon Schectman
Journal:  Am J Manag Care       Date:  2013-07-01       Impact factor: 2.229

6.  Stem cell transplantation after reduced-intensity conditioning for sickle cell disease.

Authors:  Susanne Matthes-Martin; Anita Lawitschka; Gerhard Fritsch; Thomas Lion; Brigitte Grimm; Sabine Breuer; Heidrun Boztug; Susanne Karlhuber; Wolfgang Holter; Christina Peters; Milen Minkov
Journal:  Eur J Haematol       Date:  2013-02-26       Impact factor: 2.997

7.  HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

Authors:  Javier Bolaños-Meade; Ephraim J Fuchs; Leo Luznik; Sophie M Lanzkron; Christopher J Gamper; Richard J Jones; Robert A Brodsky
Journal:  Blood       Date:  2012-09-06       Impact factor: 22.113

8.  Sickle Cell Disease: quality of life in patients with hemoglobin SS and SC disorders.

Authors:  Sônia Aparecida Dos Santos Pereira; Stela Brener; Clareci Silva Cardoso; Anna Bárbara de Freitas Carneiro Proietti
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.